FDA Inspection 1145678 — CBI Laboratories, Inc. dba Voyant Beauty LLC.

CBI Laboratories, Inc. dba Voyant Beauty LLC. — FEI 1629952

The FDA completed an inspection of CBI Laboratories, Inc. dba Voyant Beauty LLC. on July 8, 2021 in Fort Worth, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 8, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Worth, TX (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
189121 CFR 211.165(f)Failing drug products not rejected
202721 CFR 211.192Investigations of discrepancies, failures